
Delhi govt schools mandate student-made teaching aids under ‘child-friendly pedagogy' push
Under the 'Joyful Learning' programme of Samagra Shiksha-Delhi, students in classes 6 to 8 will co-develop teaching-learning materials (TLMs) with their teachers in core subjects, including languages, social science, and mathematics.
'The aim is to move away from rote memorisation and passive listening and instead introduce tools that involve touch, sight, sound and interaction to support learning', said an official. Additionally, the initiatives will be evaluated periodically based on their effectiveness, cost-effectiveness, ease of implementation, and the ability to engage multiple senses.
According to a circular issued by the department on July 24, the initiative is designed 'to enable children to become motivated and engaged in classes through observation, experimentation, drawing inferences, model building, rational reasoning, and testability'. It also seeks 'to promote student-teacher collaboration and communication'.
All government, New Delhi Municipal Council (NDMC), and Delhi Cantonment Board schools have been instructed to compulsorily adopt this during the 2025–26 academic year. The circular notes, 'Teaching-learning materials are indispensable in modern education because they enrich the learning experience by making it more interactive, accessible, and effective for students, while also providing teachers with better tools to explain, assess, and manage the classroom.'
These materials are to be developed using easily available and recyclable resources. 'Incorporating students in the creation encourages deeper engagement, creativity, collaboration, and ownership of learning,' it states. 'If the tools are co-created by teachers and students both, the onus of learning will be on both.'
The department explains that in social science, materials such as charts, maps or models help simplify complex ideas. In languages, visual and tactile aids support grammar and vocabulary acquisition. 'Multi-sensory learning with interactive activities caters to varying styles, ensuring that all students can engage with the content effectively,' the circular says.
The programme will roll out in four phases. At the school level, exhibitions held between July 15 and August 14 are being taken into consideration. Each school has an Rs 6,000 fund allocated to prepare materials and organise the event. Selected entries will move to the zonal exhibitions from August 20 to 23, followed by district-level rounds in September. A final state-level exhibition will be held in November this year as per the circular.
'This activity evolves the scope of promoting inquiry-based education and will motivate students to think critically and develop an early habit of innovative learning,' the circular states.
'The creation of TLM by students can be an integral part of child-friendly pedagogies because it promotes active engagement, creativity, inclusivity, and collaboration,' it adds.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


NDTV
an hour ago
- NDTV
Want To Live Again? German Firm Offers To Freeze Your Body For Rs 2 Crore And Revive You Later
Berlin-based startup Tomorrow Bio is offering a futuristic service that preserves the human body after legal death, aiming to give people a second chance at life. For $200,000 (Rs 1.74 Crore), the company provides full-body cryopreservation by quickly cooling the body to extremely low temperatures, which helps prevent cellular damage and decay. Since timing is critical, Tomorrow Bio runs a 24/7 emergency standby team to begin the process immediately after legal death. The idea is that future medical advancements may one day be able to revive preserved individuals. So far, over 650 people have signed up for the service, placing their trust in science and the hope that death could eventually become reversible. According to the BBC, is Europe's first cryonics lab, with a mission to freeze patients after death and potentially bring them back to life, all for a cost of $200,000 (Rs 1.74 Crore). So far, the company has cryopreserved "three or four" people and five pets, with nearly 700 more already signed up. In 2025, they plan to expand operations to cover the entire US. The BBC reported that no one has ever been successfully revived following cryopreservation, and, even if they were, the potential result could be coming back to life severely brain damaged. That there is currently no proof that organisms with brain structures as complex as humans' can successfully be restored exposes the concept as "preposterous," says Clive Coen, professor of neuroscience at King's College London. He sees pronouncements that nanotechnology (carrying out elements of the process on a nanoscale) or connectomics (mapping the brain's neurones) will bridge the current gap between theoretical biology and reality as overpromises, too. "Once you go under zero degrees, you don't want to freeze the body; you want to cryopreserve it. Otherwise, you would have ice crystals everywhere, and the tissue would get destroyed," says Emil Kendziorra, co-founder and a former cancer researcher, whose firm works both in practical and research areas of cryonics.


News18
4 hours ago
- News18
Shubhanshu Shukla To Return After Two-Week Debrief at Axiom, Microgravity Experiments Await Analysis
Shukla told the media that all the microgravity experiments of ISRO conducted on the ISS have been completed and shipped to India for analysis, though he did not share the results With post-mission rehabilitation and recovery complete, Group Captain Shubhanshu Shukla —the second Indian to travel to space—is set to return to India after a two-week debriefing at Axiom Space. Shukla was the main pilot for Axiom Mission-4, which concluded on July 15 with a successful splashdown in the Pacific Ocean on the US West Coast. Shukla travelled to the International Space Station with three other crewmates—one each from the US, Hungary, and Poland—on a private space mission funded by the respective countries. The Indian Space Research Organisation (ISRO) spent nearly Rs 550 crore on this collaboration with Axiom Space, SpaceX, and NASA. In his first press briefing after his successful return from space, Shukla mentioned that his body is adjusting well. 'It takes time to get used to gravity, find your balance, and do simple things that you were doing all your life without even giving a second thought. However, with a well-curated rehabilitation programme, I felt normal within 3-4 days. My rehabilitation has been going great—I feel I'm ready for another space mission," Shukla said virtually from Texas. 'It is difficult to give details now, but I'm excited to share that there were certain experiments where I could see the results while we were on the ISS. This was very encouraging for me. All the experiments have been shipped to researchers back home. In due course of time, we will come out with the findings and results," he added. The experiments explored muscle regeneration in space using supplements, algal growth for potential food, crop viability, microbial survivability, cognitive performance in space, and the behaviour of cyanobacteria—all aimed at understanding human spaceflight and microgravity science. Discussing the upcoming Gaganyaan mission, for which he is one of the four astronaut-designates, he said that the entire experience of going to space, conducting experiments in orbit, and the year-long training programme will be very valuable for the mission. India's first human spaceflight, Gaganyaan, is expected to launch in 2027, following multiple uncrewed test flights lined up in the coming year. The Rs 20,000 crore mission aims to send three astronauts into low Earth orbit and bring them safely back to Earth. view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.


Hans India
5 hours ago
- Hans India
India Nears Completion of Phase III Dengue Vaccine Trials
New Delhi/Hyderabad: The Ministry of Health and Family Welfare has confirmed significant progress in the Phase III trial of India's first dengue vaccine, 'DengiAll.' This clinical study, conducted by the Indian Council of Medical Research (ICMR), aims to evaluate the efficacy of a live attenuated tetravalent vaccine against all four known serotypes of the dengue virus. This update was provided in response to a question raised by Eatala Rajender, a Member of Parliament, during a Lok Sabha session on Friday. The multi-centre trial has enrolled over 10,000 participants, with more than 70% of the enrollment completed. The study is being conducted at 20 designated research centres across India, including key sites such as JSS Medical College and Hospital in Mysore (Karnataka), Bangalore Medical College & Research Institute in Bengaluru (Karnataka), and AIIMS Bibinagar in Hyderabad (Telangana). Each site has been allocated a budget of approximately Rs 1.3 to Rs 1.5 crore. Dengue remains a major public health challenge in India. Data from the Integrated Health Information Platform (IHIP) indicates that there were 573,563 laboratory-confirmed dengue cases reported in 2024, ranking the country among the top 30 worldwide for disease there is no licensed antiviral treatment or vaccine available for dengue in India. The treatment protocol is supportive, following national clinical management guidelines developed by the Union Health Ministry. These guidelines have been shared with all states and Union Territories to enhance preparedness and response capabilities during outbreaks. Given the circulation of all four dengue virus serotypes (DENV-1 to DENV-4) across different regions of India—sometimes even within the same individual—the ICMR has strategically selected trial zones that reflect this viral diversity. This method aims to assess the vaccine's broad-spectrum efficacy. In parallel, the government is implementing efforts under the National Health Mission (NHM), which include vector control measures, fogging operations, public awareness campaigns, and improved surveillance infrastructure. Sentinel Surveillance Hospitals and Apex Laboratories have been established to facilitate free diagnosis and reporting.